Release Date: 06/12/21 09:25 Summary: HSR Condition Precedent to Proposed Scheme Satisifed Price Sensitive: Yes Download Document 70.64KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status